STK11 and type 2 diabetes mellitus: Metformin is a drug commonly used to treat type 2 diabetes mellitus that delays the progression of CAC by activating the liver kinase B1/AMP-activated protein kinase (LKB1/AMPK) pathway and protects the mitochondrial structure of colonic epithelial cells while inhibiting H2O2-induced mitochondrial division [50].